biote Corp. (BTMD)
NGM · Medical Care Facilities
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients. The company was founded in 2012 and is headquartered in Irving, Texas.
Peers in Medical Care Facilities
All in industry →HCA Healthcare, Inc.
Tenet Healthcare Corporation
Fresenius Medical Care AG
The Ensign Group, Inc.
Universal Health Services, Inc.
Encompass Health Corporation
DaVita Inc.
PACS Group, Inc.
Chemed Corporation
Option Care Health, Inc.
Recent press releases
April 2026
biote Corp. — 8-K Filing
# 🧾 What This Document Is This is an 8-K filing, which is a report companies use to announce major news to investors. Attached to it is a full investor presentation (the slides starting with "Transforming Healthy Aging"). Think of the 8-K as the official cover letter, and the presentation as the de
biote Corp. — DEF 14A Filing
# 🧾 What This Document Is This is a **DEF 14A, or "Proxy Statement."** It's an official notice and information packet sent to shareholders before a company's annual meeting. Its job is to tell you what will be voted on, give you the details you need to make informed decisions, and report on key gov
SEC filings
All filings →Insider trades
All insider trades →biote Corp. has no reported insider trades in the last 90 days.